BOOK
Clinical Dermatology, An Issue of Veterinary Clinics: Small Animal Practice, E-Book
Daniel O. Morris | Robert A. Kennis
(2012)
Additional Information
Book Details
Abstract
This issue contains cutting edge information on the diagnosis and treatment of clinical dermatology. Topics will include pyoderma, antimicrobial resistance in Staphylococci, feline otitis, canine pododermatitis, diseases of the canine claw, scaling dermatoses of dogs, ischemic dermatopathies, cutaneous vasculitis, dermatologic indication for cyclosporine therapy, therapies for pruritus, and much more.
"Heart Failure will be of enormous interest and value to clinicians, investigators, and trainees who are concerned with enriching their understanding of and caring for the ever growing number of patients with this condition. We are proud of this important companion to Heart Disease: A Textbook of Cardiovascular Medicine." Forward by: Eugene Braunwald, June 2015
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Front Cover | Cover | ||
Veterinary Clinics of North America: Small Animal Practice: Clinical Dermatology | i | ||
Copyright Page | ii | ||
Table of Contents | v | ||
Contributors | iii | ||
Veterinary Clinics of North America: Small Animal Practice | viii | ||
Preface: Clinical Dermatology | ix | ||
Chapter 1. Recognizing Pyoderma: More Difficult than it May Seem | 1 | ||
INTRODUCTION | 1 | ||
IS THIS PYODERMA? | 2 | ||
UNUSUAL MANIFESTATIONS OF PYODERMA OR BACTERIAL OVERGROWTH | 3 | ||
CONDITIONS EASILY MISTAKEN FOR PYODERMA | 7 | ||
CUTANEOUS CYTOLOGY | 9 | ||
BACTERIAL CULTURE AND SENSITIVITY | 14 | ||
HISTOPATHOLOGY | 16 | ||
RESPONSE TO THERAPY | 16 | ||
SUMMARY | 16 | ||
REFERENCES | 16 | ||
Chapter 2. Antimicrobial Resistance in Staphylococci in Small Animals | 19 | ||
INTRODUCTION | 19 | ||
METHICILLIN RESISTANCE | 20 | ||
METHICILLIN-RESISTANT STAPHYLOCOCCI OF VETERINARY IMPORTANCE | 20 | ||
OTHER MECHANISMS OF STAPHYLOCOCCAL ANTIMICROBIAL RESISTANCE | 25 | ||
IMPLICATIONS OF STAPHYLOCOCCAL ANTIMICROBIAL RESISTANCE | 26 | ||
SUMMARY | 29 | ||
REFERENCES | 30 | ||
Chapter 3. Topical Therapy for Drug-Resistant Pyoderma in Small Animals | 41 | ||
SHAMPOO/LEAVE-ON CONDITIONER THERAPY | 42 | ||
OINTMENT/CREAM/GEL/LIQUID THERAPY | 43 | ||
SPRAYS AND DIPS | 44 | ||
WIPES | 44 | ||
POTENTIATING INGREDIENTS | 45 | ||
REFERENCES | 48 | ||
Chapter 4. Feline Otitis: Diagnosis and Treatment | 51 | ||
INTRODUCTION | 51 | ||
DIFFERENTIAL DIAGNOSES | 52 | ||
DIAGNOSTIC PROCEDURES | 54 | ||
TREATMENT OPTIONS | 54 | ||
SUGGESTED READINGS | 56 | ||
Chapter 5. Canine Pododermatitis | 57 | ||
INTRODUCTION | 57 | ||
INFECTIOUS/PARASITIC DISEASES OF THE PAWS | 58 | ||
IMMUNOLOGIC DISEASE OF THE CANINE PAW | 71 | ||
METABOLIC DISEASES OF THE CANINE PAW | 78 | ||
NEOPLASTIC DISEASES OF THE CANINE PAW | 79 | ||
INHERITED/GENETIC DISEASES OF THE CANINE PAW | 83 | ||
FOREIGN BODY CONDITIONS THAT AFFECT THE CANINE PAW | 84 | ||
REFERENCES | 86 | ||
Chapter 6. Canine Ichthyosis and Related Disorders of Cornification | 89 | ||
INTRODUCTION | 89 | ||
DIAGNOSTIC APPROACH | 90 | ||
PATHOPHYSIOLOGY | 90 | ||
ICHTHYOSIS: GENERAL | 91 | ||
EPIDERMOLYTIC ICHTHYOSIS | 91 | ||
NONEPIDERMOLYTIC ICHTHYOSIS | 91 | ||
GOLDEN RETRIEVER ICHTHYOSIS | 92 | ||
AMERICAN BULLDOG ICHTHYOSIS | 92 | ||
JACK RUSSELL TERRIER ICHTHYOSIS | 93 | ||
ICHTHYOSES NOT CHARACTERIZED | 93 | ||
DIFFERENTIAL DIAGNOSIS FOR ICHTHYOSIFORM DISORDERS | 93 | ||
TREATMENT OF PRIMARY DOC | 94 | ||
UNCONFIRMED PRIMARY DOC | 94 | ||
GENERALIZED SEBACEOUS GLAND HYPERPLASIA OF TERRIERS | 95 | ||
PRIMARY SEBORRHEA: A CONTROVERSY | 95 | ||
REFERENCES | 96 | ||
Chapter 7. Ischemic Dermatopathies | 99 | ||
INTRODUCTION | 99 | ||
CANINE FAMILIAL DERMATOMYOSITIS: DISEASE OVERVIEW | 100 | ||
RABIES VACCINE–INDUCED VASCULITIS WITH ALOPECIA: DISEASE OVERVIEW | 104 | ||
VACCINE-ASSOCIATED ISCHEMIC DERMATOPATHY: DISEASE OVERVIEW | 105 | ||
OTHER ISCHEMIC DERMATOPATHIES: OVERVIEWS | 107 | ||
REFERENCES | 109 | ||
Chapter 8. Cutaneous Vasculitis in Small Animals | 113 | ||
IMMUNOPATHOGENESIS | 114 | ||
HISTOLOGIC FEATURES | 114 | ||
CLASSIFICATION | 115 | ||
CLINICAL FINDINGS | 115 | ||
DIAGNOSIS | 119 | ||
DIFFERENTIAL DIAGNOSES | 120 | ||
TRIGGERS AND UNDERLYING DISEASES | 120 | ||
TREATMENT | 128 | ||
SUMMARY | 131 | ||
REFERENCES | 132 | ||
Chapter 9. Cutaneous Manifestations of Internal Diseases | 135 | ||
INTRODUCTION | 135 | ||
CUTANEOUS CHANGES ASSOCIATED WITH HORMONAL DISTURBANCES | 136 | ||
CUTANEOUS PARANEOPLASTIC MARKERS | 138 | ||
CUTANEOUS MANIFESTATIONS OF NUTRITIONAL OR METABOLIC PERTURBATIONS | 141 | ||
CUTANEOUS MANIFESTATIONS OF SYSTEMIC INFECTIOUS DISEASES | 146 | ||
AUTOIMMUNE SKIN DISEASES ASSOCIATED WITH SYSTEMIC DISEASE | 148 | ||
REFERENCES | 150 | ||
Chapter 10. Cyclosporine in Veterinary Dermatology | 153 | ||
INTRODUCTION | 153 | ||
FORMULATIONS OF CYCLOSPORINE | 153 | ||
MECHANISM OF ACTION | 154 | ||
PHARMACOKINETICS | 154 | ||
MONITORING BLOOD LEVELS OF CYCLOSPORINE | 155 | ||
DRUG INTERACTIONS | 156 | ||
SIDE EFFECTS IN DOGS | 157 | ||
SIDE EFFECTS IN CATS | 160 | ||
EFFECT OF CYCLOSPORINE ON VACCINATION | 161 | ||
EFFECT OF CSA ON ALLERGY TESTING | 162 | ||
CSA AND ALLERGEN-SPECIFIC IMMUNOTHERAPY | 162 | ||
DERMATOLOGIC USES/INDICATIONS | 162 | ||
IMMUNE-MEDIATED SKIN DISEASES | 163 | ||
MISCELLANEOUS DERMATOLOGIC CONDITIONS | 165 | ||
PATIENT MONITORING DURING CYCLOSPORINE THERAPY | 166 | ||
SUMMARY | 166 | ||
REFERENCES | 166 | ||
Chapter 11. Nonsteroidal, Nonimmunosuppressive Therapies for Pruritus | 173 | ||
INTRODUCTION | 173 | ||
CAUSES OF PRURITUS | 174 | ||
TREATMENT OVERVIEW | 174 | ||
TOPICAL THERAPY OVERVIEW | 174 | ||
TOPICAL THERAPY—MECHANISM OF ACTION | 175 | ||
PRURITUS AND ATOPIC DERMATITIS | 178 | ||
BATHING | 178 | ||
COMPONENTS OF GOOD SKIN CARE | 178 | ||
EPIDERMAL BARRIER DYSFUNCTION | 179 | ||
CONSEQUENCES OF BARRIER DYSFUNCTION | 179 | ||
TREATMENT OF BARRIER DYSFUNCTION AND PRURITUS | 180 | ||
LIPID REPLACEMENT LOTIONS | 180 | ||
CLINICAL APPLICATION OF LOTIONS | 181 | ||
SYSTEMIC TREATMENT OF PRURITUS | 181 | ||
ANTIHISTAMINES THERAPY | 181 | ||
TRICYCLIC ANTIDEPRESSANTS AND MISCELLANEOUS OTHER MEDICATIONS | 182 | ||
FATTY ACIDS THERAPY | 183 | ||
ANTIMICROBIAL THERAPY | 183 | ||
SUMMARY | 184 | ||
REFERENCES | 184 | ||
Chapter 12. Alternative Therapies in Veterinary Dermatology | 189 | ||
INTRODUCTION | 189 | ||
TRADITIONAL CHINESE MEDICINE | 190 | ||
ACUPUNCTURE | 191 | ||
CHINESE HERBS | 193 | ||
HOMEOPATHY | 194 | ||
WESTERN HERBS AND PLANT EXTRACTS | 195 | ||
CAPSAICIN | 196 | ||
HARDY KIWI | 196 | ||
TEA TREE OIL | 197 | ||
CHAMOMILE | 197 | ||
CALENDULA | 198 | ||
OATMEAL | 198 | ||
ALOE VERA | 198 | ||
SUMMARY | 199 | ||
REFERENCES | 199 | ||
Index | 205 |